×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TXG – 10x genomics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TXG
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/31
08:41 am
txg
10x Genomics (TXG) was upgraded by William Blair from "market perform" to "outperform".
Low
Report
10x Genomics (TXG) was upgraded by William Blair from "market perform" to "outperform".
3/25
07:00 am
txg
Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
Low
Report
Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
3/25
07:00 am
txg
Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
Low
Report
Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
3/25
07:00 am
txg
Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
Low
Report
Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
3/17
08:12 am
txg
PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas [Yahoo! Finance]
Medium
Report
PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas [Yahoo! Finance]
3/17
08:00 am
txg
PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas
Medium
Report
PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas
3/6
05:58 pm
txg
Life Sciences Tools & Services Stocks Q4 In Review: 10x Genomics (NASDAQ:TXG) Vs Peers [Yahoo! Finance]
Low
Report
Life Sciences Tools & Services Stocks Q4 In Review: 10x Genomics (NASDAQ:TXG) Vs Peers [Yahoo! Finance]
3/2
09:04 am
txg
10x Genomics (TXG) had its price target raised by Stifel Nicolaus from $20.00 to $25.00. They now have a "buy" rating on the stock.
Medium
Report
10x Genomics (TXG) had its price target raised by Stifel Nicolaus from $20.00 to $25.00. They now have a "buy" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/25
05:15 pm
txg
Form 4 10x Genomics, Inc. For: Mar 23 Filed by: Saxonov Serge
Low
Report
Form 4 10x Genomics, Inc. For: Mar 23 Filed by: Saxonov Serge
3/25
03:07 pm
txg
Form SCHEDULE 13G/A 10x Genomics, Inc. Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A 10x Genomics, Inc. Filed by: VANGUARD GROUP INC
3/24
04:15 pm
txg
Form SCHEDULE 13G/A 10x Genomics, Inc. Filed by: VANGUARD GROUP INC
Medium
Report
Form SCHEDULE 13G/A 10x Genomics, Inc. Filed by: VANGUARD GROUP INC
3/6
10:16 am
txg
Form SCHEDULE 13G/A 10x Genomics, Inc. Filed by: FMR LLC
Low
Report
Form SCHEDULE 13G/A 10x Genomics, Inc. Filed by: FMR LLC
3/4
04:14 pm
txg
Form 4 10x Genomics, Inc. For: Mar 02 Filed by: Saxonov Serge
Low
Report
Form 4 10x Genomics, Inc. For: Mar 02 Filed by: Saxonov Serge
3/2
04:25 pm
txg
Form 4 10x Genomics, Inc. For: Feb 26 Filed by: Saxonov Serge
Low
Report
Form 4 10x Genomics, Inc. For: Feb 26 Filed by: Saxonov Serge
3/2
04:24 pm
txg
Form 4 10x Genomics, Inc. For: Feb 26 Filed by: Hindson Benjamin J.
Low
Report
Form 4 10x Genomics, Inc. For: Feb 26 Filed by: Hindson Benjamin J.
3/2
04:23 pm
txg
Form 4 10x Genomics, Inc. For: Feb 26 Filed by: Taich Adam
Low
Report
Form 4 10x Genomics, Inc. For: Feb 26 Filed by: Taich Adam
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
12/19
Form 8-K 10x Genomics, Inc. For: Dec 18
19.6%
2/27 Form 10-K 10x Genomics, Inc. For: Dec 31 9.6%
9/18 Form 3 10x Genomics, Inc. For: Sep 11 Filed by: Paladin Capital Cyber Group, LLC 8.8%
11/9 10x Genomics Inc (TXG) Q3 2019 Earnings Call Transcript [The Motley Fool] 8.2%
3/9 Form 4 10x Genomics, Inc. For: Mar 06 Filed by: CRUTCHFIELD BRADFORD 7.3%
10/25 10x Genomics to Report Third Quarter 2019 Financial Results on November 7, 2019 6.8%
12/20 10x Genomics and Care.com among Tech gainers; CalAmp and Technical Communications among losers [Seeking Alpha] 6.8%
2/14 Form 8-K 10x Genomics, Inc. For: Feb 12 6.7%
4/3 Form 4 10x Genomics, Inc. For: Apr 01 Filed by: CRUTCHFIELD BRADFORD 6.1%
4/7 Form 4 10x Genomics, Inc. For: Apr 06 Filed by: Saxonov Serge 5.7%
2/27 Form 10-K 10x Genomics, Inc. For: Dec 31 9.6%
9/18 Form 3 10x Genomics, Inc. For: Sep 11 Filed by: Paladin Capital Cyber Group, LLC 8.8%
11/9 10x Genomics Inc (TXG) Q3 2019 Earnings Call Transcript [The Motley Fool] 8.2%
3/9 Form 4 10x Genomics, Inc. For: Mar 06 Filed by: CRUTCHFIELD BRADFORD 7.3%
10/25 10x Genomics to Report Third Quarter 2019 Financial Results on November 7, 2019 6.8%
12/20 10x Genomics and Care.com among Tech gainers; CalAmp and Technical Communications among losers [Seeking Alpha] 6.8%
2/14 Form 8-K 10x Genomics, Inc. For: Feb 12 6.7%
4/3 Form 4 10x Genomics, Inc. For: Apr 01 Filed by: CRUTCHFIELD BRADFORD 6.1%
4/7 Form 4 10x Genomics, Inc. For: Apr 06 Filed by: Saxonov Serge 5.7%
TOP News Decliners
9/24
10x Genomics (NYSE: TXG) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.
-10.0%
2/25 10x Genomics to Present at the 40th Annual Cowen Health Care Conference -8.0%
1/30 The Daily Biotech Pulse: Novartis Earnings, Hepion's NASH Candidate Beats Rival Drugs, Annovis Bio To Debut [Yahoo! Finance News] -7.4%
3/5 10x Genomics (NYSE: TXG) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock. -6.2%
12/11 Form 8-K 10x Genomics, Inc. For: Dec 11 -5.6%
3/18 Form 3 10x Genomics, Inc. For: Sep 11 Filed by: SOFTBANK VISION FUND (AIV M2) L.P. -5.2%
12/12 Form 8-K 10x Genomics, Inc. For: Dec 12 -4.7%
9/12 Form 4 10x Genomics, Inc. For: Sep 11 Filed by: ROBERTS BRYAN E -4.1%
1/7 10x Genomics to Present at the 38th Annual J.P. Morgan Healthcare Conference -3.3%
11/26 10x Genomics Begins Shipments of Visium Spatial Gene Expression Solution -3.0%
2/25 10x Genomics to Present at the 40th Annual Cowen Health Care Conference -8.0%
1/30 The Daily Biotech Pulse: Novartis Earnings, Hepion's NASH Candidate Beats Rival Drugs, Annovis Bio To Debut [Yahoo! Finance News] -7.4%
3/5 10x Genomics (NYSE: TXG) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock. -6.2%
12/11 Form 8-K 10x Genomics, Inc. For: Dec 11 -5.6%
3/18 Form 3 10x Genomics, Inc. For: Sep 11 Filed by: SOFTBANK VISION FUND (AIV M2) L.P. -5.2%
12/12 Form 8-K 10x Genomics, Inc. For: Dec 12 -4.7%
9/12 Form 4 10x Genomics, Inc. For: Sep 11 Filed by: ROBERTS BRYAN E -4.1%
1/7 10x Genomics to Present at the 38th Annual J.P. Morgan Healthcare Conference -3.3%
11/26 10x Genomics Begins Shipments of Visium Spatial Gene Expression Solution -3.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: